For the year ending 2025-12-31, INBX made $1,300K in revenue. -$140,055K in net income. Net profit margin of -10773.46%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenue | 1,300 | |||
| Research and development | 113,028 | |||
| General and administrative | 23,297 | |||
| Total operating expenses | 136,325 | |||
| Loss from operations | -135,025 | |||
| Gain related to transaction with acquirer | 0 | |||
| Interest expense | 12,196 | |||
| Interest income | 7,549 | |||
| Other income (expense), net | -381 | |||
| Total other income (expense) | -5,028 | |||
| Income (loss) before provision for income taxes | -140,053 | |||
| Provision for income taxes | 2 | |||
| Net income (loss) | -140,055 | |||
| Basic EPS | -9.04 | |||
| Diluted EPS | -9.04 | |||
| Basic Average Shares | 15,487,000 | |||
| Diluted Average Shares | 15,487,000 | |||
Inhibrx Biosciences, Inc. (INBX)
Inhibrx Biosciences, Inc. (INBX)